Andrew F. Adler

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.

H. Bjartmarz, A. Landau, B. Mattsson, 2023, Cell stem cell.

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD

H. Bjartmarz, A. Landau, B. Mattsson, 2022 .

Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinsonâ€TMs disease

Åsa K. Björklund, T. Perlmann, Andrew F Adler, 2020 .